Therapeutic management of bone demineralization in the HIV-infected population.
Negredo
Eugènia
E
Martínez
Eva
E
Cinquegrana
Denise
D
Estany
Carla
C
Clotet
Bonaventura
B
D019386:Alendronate / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015519:Bone Density / Q000502:physiology*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008019:Life Style
D019380:Anti-HIV Agents; D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates; D019386:Alendronate